Title
DDB Regulation on Drug Test Fees
Law
Ddb Board Regulation No. 01, S. 2004
Decision Date
Feb 27, 2004
The Dangerous Drugs Board prescribes drug testing fees of P200 for government-owned and up to P250 for private laboratories, enforcing penalties for non-compliance to ensure standardized pricing across accredited facilities.

Prescribed Drug Test Fees

  • Government-owned laboratories may charge a fee of P200.00 per person.
  • Private drug testing laboratories are authorized to charge a fee not exceeding P250.00 per person.
  • Fees include the cost for initial screening as well as any necessary confirmatory tests.

Administrative Sanctions for Overcharging

  • Laboratories charging fees above the prescribed amounts are subject to sanctions, contingent on existing rules and after due notice.
  • For the first offense, the laboratory receives a reprimand.
  • Upon a second offense, suspension of the laboratory's License to Operate will be enforced.
  • A third offense leads to revocation of the License to Operate.

Effectivity of the Regulation

  • The regulation becomes effective fifteen (15) days after its publication in two newspapers of general circulation.
  • It must also be registered with the Office of the National Administrative Register (ONAR) at the UP Law Center, Quezon City.

Legal Authority and Signatories

  • The regulation is issued pursuant to the powers granted to the Dangerous Drugs Board under Section 81(b), Article IX of RA 9165.
  • It reflects decisions made by the Board during its 68th meeting on February 13, 2004.
  • The document bears the signatures of various ex-officio members and representatives from key government departments and non-government organizations involved in drug enforcement and policy.

Important Legal Concepts

  • Accreditation by the Department of Health is mandatory for laboratories to impose the prescribed fees.
  • Fee includes comprehensive testing (screening and confirmation).
  • Sanctions for non-compliance signal strict regulatory oversight aimed at consumer protection and standardization in drug testing fees.
  • The provision underscores government oversight in the private and public laboratory sector concerning drug testing costs and practices.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.